abstract |
Disclosed is the use of a 15-keto-prostaglandin compound, particularly of formula (I), for producing a pharmaceutical composition for treatment of a subject having a disease or condition associated with bile secretion disorder, and for promoting bile secretion of a liver to be transplanted in a liver transplantation process. |